| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 172.764.205 $ | +1.451.955 $ | +0,6 % | 4 | 171.312.250 $ | +171.312.250 $ | 4 | |||||
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 64.617.637 $ | +2.323.529 $ | +3,7 % | 1 | 62.294.108 $ | +62.294.108 $ | 1 | |
| Bicara Therapeutics Inc. | BCAX | → 0 | Neutral | 46.688.333 $ | +823.356 $ | +1,8 % | 1 | 45.864.977 $ | +45.864.977 $ | 1 | |
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Stark | 36.615.386 $ | +6.615.385 $ | +22,1 % | 1 | 30.000.001 $ | +30.000.001 $ | 1 | |
| Biohaven Ltd. | BHVN | → 0 | Schwach | 24.842.849 $ | -8.310.315 $ | -25,1 % | 1 | 33.153.164 $ | +33.153.164 $ | 1 | |
| 172.764.205 $ | +1.451.955 $ | +0,6 % | 4 | 171.312.250 $ | +171.312.250 $ | 4 | |||||